COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbbVie Inc. | Common | 00287Y109 | 27,795 | 481,219 | SH | | SOLE | | 481,219 | 0 | 0 |
Accuray, Inc. | Common | 004397105 | 5,314 | 731,943 | SH | | SOLE | | 731,943 | 0 | 0 |
Acorda Therapeutics, Inc. | Common | 00484M106 | 9,255 | 273,162 | SH | | SOLE | | 273,162 | 0 | 0 |
Acorda Therapeutics, Inc. | Common | 00484M106 | 1,606 | 47,400 | SH | Call | SOLE | | 47,400 | 0 | 0 |
Actavis plc | Shares | G0083B108 | 66,987 | 277,631 | SH | | SOLE | | 277,631 | 0 | 0 |
Aetna, Inc. | Common | 00817Y108 | 31,512 | 389,031 | SH | | SOLE | | 389,031 | 0 | 0 |
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 2,147 | 35,000 | SH | | SOLE | | 35,000 | 0 | 0 |
Akorn, Inc. | Common | 009728106 | 25,367 | 699,382 | SH | | SOLE | | 699,382 | 0 | 0 |
Alere, Inc. | Common | 01449J105 | 11,553 | 297,901 | SH | | SOLE | | 297,901 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 74,935 | 451,905 | SH | | SOLE | | 451,905 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 4,444 | 26,800 | SH | Call | SOLE | | 26,800 | 0 | 0 |
Align Technology, Inc. | Common | 016255101 | 3,638 | 70,400 | SH | | SOLE | | 70,400 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 18,733 | 436,970 | SH | | SOLE | | 436,970 | 0 | 0 |
Allergan Inc. | Common | 018490102 | 40,668 | 228,227 | SH | | SOLE | | 228,227 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 4,811 | 61,595 | SH | | SOLE | | 61,595 | 0 | 0 |
Amarin Corporation plc | Sponsored ADR | 023111206 | 6,151 | 5,643,412 | SH | | SOLE | | 5,643,412 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 71,640 | 510,042 | SH | | SOLE | | 510,042 | 0 | 0 |
BioDelivery Sciences International, Inc. | Common | 09060J106 | 8,572 | 501,553 | SH | | SOLE | | 501,553 | 0 | 0 |
Biogen Idec, Inc. | Common | 09062X103 | 61,790 | 186,783 | SH | | SOLE | | 186,783 | 0 | 0 |
Biogen Idec, Inc. | Common | 09062X103 | 4,234 | 12,800 | SH | Call | SOLE | | 12,800 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 51,272 | 710,527 | SH | | SOLE | | 710,527 | 0 | 0 |
bluebird Bio, Inc. | Common | 09609G100 | 6,205 | 172,927 | SH | | SOLE | | 172,927 | 0 | 0 |
bluebird Bio, Inc. | Common | 09609G100 | 4,248 | 118,400 | SH | Call | SOLE | | 118,400 | 0 | 0 |
Bristol-Myers Squibb Co. | Common | 110122108 | 27,394 | 535,240 | SH | | SOLE | | 535,240 | 0 | 0 |
Catamaran Corporation | Common | 148887102 | 18,276 | 433,600 | SH | | SOLE | | 433,600 | 0 | 0 |
Celgene Corporation | Common | 151020104 | 193,013 | 2,036,434 | SH | | SOLE | | 2,036,434 | 0 | 0 |
Celgene Corporation | Common | 151020104 | 17,136 | 180,800 | SH | Call | SOLE | | 180,800 | 0 | 0 |
Celladon Corporation | Common | 15117E107 | 9,644 | 970,495 | SH | | SOLE | | 970,495 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B103 | 6,589 | 508,400 | SH | | SOLE | | 508,400 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B103 | 6,589 | 508,400 | SH | Call | SOLE | | 508,400 | 0 | 0 |
Centene Corporation | Common | 15135B101 | 4,963 | 60,000 | SH | | SOLE | | 60,000 | 0 | 0 |
Cigna Corp | Common | 125509109 | 11,087 | 122,251 | SH | | SOLE | | 122,251 | 0 | 0 |
Clovis Oncology, Inc. | Common | 189464100 | 4,720 | 104,051 | SH | | SOLE | | 104,051 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 8,474 | 154,672 | SH | | SOLE | | 154,672 | 0 | 0 |
Corsicanto Ltd. | Note 3.5% 1/15/32 | 220480AB3 | 5,786 | 8,700,000 | PRN | | SOLE | | 8,700,000 | 0 | 0 |
Cubist Pharmaceuticals, Inc. | Common | 229678107 | 32,802 | 494,454 | SH | | SOLE | | 494,454 | 0 | 0 |
Eli Lilly & Co | Common | 532457108 | 12,122 | 186,918 | SH | | SOLE | | 186,918 | 0 | 0 |
Endo International PLC | Shares | G30401106 | 22,977 | 336,215 | SH | | SOLE | | 336,215 | 0 | 0 |
Endologix Inc. | Common | 29266S106 | 5,841 | 551,000 | SH | | SOLE | | 551,000 | 0 | 0 |
Epizyme, Inc. | Common | 29428V104 | 3,830 | 141,262 | SH | | SOLE | | 141,262 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 265,117 | 2,490,531 | SH | | SOLE | | 2,490,531 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 17,128 | 160,900 | SH | Call | SOLE | | 160,900 | 0 | 0 |
HCA Holdings, Inc. | Common | 40412C101 | 8,158 | 115,688 | SH | | SOLE | | 115,688 | 0 | 0 |
Health Care REIT Inc. | Common | 42217K601 | 11,436 | 200,000 | PRN | | SOLE | | 200,000 | 0 | 0 |
Heron Therapeutics, Inc. | Common | 427746102 | 7,280 | 873,940 | SH | | SOLE | | 873,940 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 6,630 | 56,265 | SH | | SOLE | | 56,265 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 37,594 | 229,341 | SH | | SOLE | | 229,341 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 3,869 | 23,600 | SH | Call | SOLE | | 23,600 | 0 | 0 |
Impax Laboratories, Inc. | Common | 45256B101 | 23,480 | 990,283 | SH | | SOLE | | 990,283 | 0 | 0 |
Impax Laboratories, Inc. | Common | 45256B101 | 7,649 | 322,600 | SH | Call | SOLE | | 322,600 | 0 | 0 |
Incyte Corporation | Common | 45337C102 | 56,013 | 1,141,961 | SH | | SOLE | | 1,141,961 | 0 | 0 |
Incyte Corporation | Common | 45337C102 | 4,586 | 93,500 | SH | Call | SOLE | | 93,500 | 0 | 0 |
Infinity Pharmaceuticals, Inc. | Common | 45665G303 | 9,136 | 680,746 | SH | | SOLE | | 680,746 | 0 | 0 |
IntelliPharmaceutics International Inc. | Common | 458173101 | 4,226 | 1,404,000 | SH | | SOLE | | 1,404,000 | 0 | 0 |
Ironwood Pharmaceuticals, Inc. | Common | 46333X108 | 9,950 | 768,050 | SH | | SOLE | | 768,050 | 0 | 0 |
Ishares Nasdaq Biotechnology ETF | ETF | 464287556 | 21,719 | 79,375 | SH | | SOLE | | 79,375 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 27,816 | 173,241 | SH | | SOLE | | 173,241 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 34,878 | 327,212 | SH | | SOLE | | 327,212 | 0 | 0 |
Karyopharm Therapeutics Inc. | Common | 48576U106 | 3,563 | 101,966 | SH | | SOLE | | 101,966 | 0 | 0 |
KYTHERA Biopharmaceuticals Inc. | Common | 501570105 | 3,651 | 111,433 | SH | | SOLE | | 111,433 | 0 | 0 |
Ligand Pharmaceuticals Inc. | Common | 53220K504 | 3,252 | 69,200 | SH | | SOLE | | 69,200 | 0 | 0 |
LTC Properties Inc. | Common | 502175102 | 8,729 | 236,618 | SH | | SOLE | | 236,618 | 0 | 0 |
Macrogenics, Inc. | Common | 556099109 | 666 | 31,857 | SH | | SOLE | | 31,857 | 0 | 0 |
McKesson Corporation | Common | 58155Q103 | 13,211 | 67,862 | SH | | SOLE | | 67,862 | 0 | 0 |
Medical Properties Trust Inc. | Common | 58463J304 | 7,690 | 627,274 | SH | | SOLE | | 627,274 | 0 | 0 |
MEI Pharma, Inc. | Common | 55279B202 | 1,683 | 243,920 | SH | | SOLE | | 243,920 | 0 | 0 |
Merrimack Pharmaceuticals, Inc. | Note 4.50% 7/15/20 | 590328AA8 | 2,308 | 1,485,000 | PRN | | SOLE | | 1,485,000 | 0 | 0 |
Merrimack Pharmaceuticals, Inc. | Common | 590328100 | 4,985 | 567,787 | SH | | SOLE | | 567,787 | 0 | 0 |
Molina Healthcare, Inc. | Common | 60855R100 | 14,716 | 347,901 | SH | | SOLE | | 347,901 | 0 | 0 |
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 12,106 | 1,067,575 | SH | | SOLE | | 1,067,575 | 0 | 0 |
Mylan, Inc. | Common | 628530107 | 45,950 | 1,010,105 | SH | | SOLE | | 1,010,105 | 0 | 0 |
Myriad Genetics, Inc. | Common | 62855J104 | 4,328 | 112,200 | SH | | SOLE | | 112,200 | 0 | 0 |
Myriad Genetics, Inc. | Common | 62855J104 | 4,328 | 112,200 | SH | Call | SOLE | | 112,200 | 0 | 0 |
Nektar Therapeutics | Common | 640268108 | 4,041 | 334,800 | SH | | SOLE | | 334,800 | 0 | 0 |
Nektar Therapeutics | Common | 640268108 | 4,041 | 334,800 | SH | Call | SOLE | | 334,800 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 20,088 | 1,281,950 | SH | | SOLE | | 1,281,950 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 4,413 | 281,600 | SH | Call | SOLE | | 281,600 | 0 | 0 |
NPS Pharmaceuticals, Inc. | Common | 62936P103 | 6,211 | 238,900 | SH | | SOLE | | 238,900 | 0 | 0 |
NPS Pharmaceuticals, Inc. | Common | 62936P103 | 4,056 | 156,000 | SH | Call | SOLE | | 156,000 | 0 | 0 |
Omega Healthcare Investors Inc. | Common | 681936100 | 8,637 | 252,616 | SH | | SOLE | | 252,616 | 0 | 0 |
OncoGenex Pharmaceuticals, Inc. | Common | 68230A106 | 302 | 113,100 | SH | | SOLE | | 113,100 | 0 | 0 |
PerkinElmer, Inc. | Common | 714046109 | 7,216 | 165,495 | SH | | SOLE | | 165,495 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 9,455 | 62,952 | SH | | SOLE | | 62,952 | 0 | 0 |
Pfizer, Inc. | Common | 717081103 | 56,249 | 1,902,241 | SH | | SOLE | | 1,902,241 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 9,216 | 671,702 | SH | | SOLE | | 671,702 | 0 | 0 |
PTC Therapeutics, Inc. | Common | 69366J200 | 3,483 | 79,150 | SH | | SOLE | | 79,150 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 67,477 | 187,166 | SH | | SOLE | | 187,166 | 0 | 0 |
Sabra Health Care REIT Inc. | Common | 78573L106 | 8,351 | 343,390 | SH | | SOLE | | 343,390 | 0 | 0 |
Sage Therapeutics, Inc. | Common | 78667J108 | 158 | 5,000 | SH | | SOLE | | 5,000 | 0 | 0 |
Sagent Pharmaceuticals, Inc. | Common | 786692103 | 12,587 | 404,731 | SH | | SOLE | | 404,731 | 0 | 0 |
Sangamo BioSciences, Inc. | Common | 800677106 | 8,090 | 750,100 | SH | | SOLE | | 750,100 | 0 | 0 |
Sarepta Therapeutics Inc. | Common | 803607100 | 7,288 | 345,400 | SH | | SOLE | | 345,400 | 0 | 0 |
Sarepta Therapeutics Inc. | Common | 803607100 | 7,288 | 345,400 | SH | Call | SOLE | | 345,400 | 0 | 0 |
Senior Housing Properties Trust | Shares | 81721M109 | 8,567 | 409,504 | SH | | SOLE | | 409,504 | 0 | 0 |
Shire plc | Sponsored ADR | 82481R106 | 31,947 | 123,322 | SH | | SOLE | | 123,322 | 0 | 0 |
St Jude Medical, Inc. | Common | 790849103 | 7,367 | 122,510 | SH | | SOLE | | 122,510 | 0 | 0 |
Stryker Corporation | Common | 863667101 | 7,739 | 95,840 | SH | | SOLE | | 95,840 | 0 | 0 |
Synageva BioPharma Corp. | Common | 87159A103 | 15,339 | 223,020 | SH | | SOLE | | 223,020 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Common | 881624209 | 3,687 | 68,600 | SH | Call | SOLE | | 68,600 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | ADR | 881624209 | 35,055 | 652,194 | SH | | SOLE | | 652,194 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 32,479 | 266,875 | SH | | SOLE | | 266,875 | 0 | 0 |
Thoratec Corporation | Common | 885175307 | 3,029 | 113,300 | SH | | SOLE | | 113,300 | 0 | 0 |
UnitedHealth Group, Inc. | Common | 91324P102 | 7,175 | 83,186 | SH | | SOLE | | 83,186 | 0 | 0 |
Ventas Inc. | Common | 92276F100 | 8,449 | 136,382 | SH | | SOLE | | 136,382 | 0 | 0 |
Verastem, Inc. | Common | 92337C104 | 9,797 | 1,149,827 | SH | | SOLE | | 1,149,827 | 0 | 0 |
Vertex Pharmaceuticals, Inc. | Common | 92532F100 | 78,835 | 701,944 | SH | | SOLE | | 701,944 | 0 | 0 |
WellCare Health Plans Inc. | Common | 94946T106 | 5,349 | 88,652 | SH | | SOLE | | 88,652 | 0 | 0 |
Zimmer Holdings, Inc. | Common | 98956P102 | 8,024 | 79,800 | SH | | SOLE | | 79,800 | 0 | 0 |